These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32980365)

  • 1. Dutasteride combined with androgen receptor antagonists inhibit glioblastoma U87 cell metabolism, proliferation, and invasion capacity: Androgen regulation.
    Orozco M; Valdez RA; Ramos L; Cabeza M; Segovia J; Romano MC
    Steroids; 2020 Dec; 164():108733. PubMed ID: 32980365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of finasteride and dutasteride on the synthesis of neurosteroids by glioblastoma cells.
    Pinacho-Garcia LM; Valdez RA; Navarrete A; Cabeza M; Segovia J; Romano MC
    Steroids; 2020 Mar; 155():108556. PubMed ID: 31866547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer.
    Seok J; Kwak HJ; Kwak Y; Lee M; Park KS; Kim A; Cho SG
    J Transl Med; 2023 Feb; 21(1):129. PubMed ID: 36800968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma cells express crucial enzymes involved in androgen synthesis: 3β-hydroxysteroid dehydrogenase, 17-20α-hydroxylase, 17β-hydroxysteroid dehydrogenase and 5α-reductase.
    Mondragón JA; Serrano Y; Torres A; Orozco M; Segovia J; Manjarrez G; Romano MC
    Endocrinol Diabetes Metab; 2021 Oct; 4(4):e00289. PubMed ID: 34505421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific.
    Chhipa RR; Halim D; Cheng J; Zhang HY; Mohler JL; Ip C; Wu Y
    Prostate; 2013 Oct; 73(14):1483-94. PubMed ID: 23813737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro.
    Pham S; Deb S; Ming DS; Adomat H; Hosseini-Beheshti E; Zoubeidi A; Gleave M; Guns ES
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():436-44. PubMed ID: 25201454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.
    Li Z; Alyamani M; Li J; Rogacki K; Abazeed M; Upadhyay SK; Balk SP; Taplin ME; Auchus RJ; Sharifi N
    Nature; 2016 May; 533(7604):547-51. PubMed ID: 27225130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation.
    Hamid AR; Verhaegh GW; Smit FP; van Rijt-van de Westerlo C; Armandari I; Brandt A; Sweep FC; Sedelaar JP; Schalken JA
    J Urol; 2015 Mar; 193(3):1023-9. PubMed ID: 25242390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.
    Ateeq B; Vellaichamy A; Tomlins SA; Wang R; Cao Q; Lonigro RJ; Pienta KJ; Varambally S
    Prostate; 2012 Oct; 72(14):1542-9. PubMed ID: 22415461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines.
    Biancolella M; Valentini A; Minella D; Vecchione L; D'Amico F; Chillemi G; Gravina P; Bueno S; Prosperini G; Desideri A; Federici G; Bernardini S; Novelli G
    Invest New Drugs; 2007 Oct; 25(5):491-7. PubMed ID: 17636412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activational action of testosterone on androgen receptors protects males preventing temporomandibular joint pain.
    Fanton LE; Macedo CG; Torres-Chávez KE; Fischer L; Tambeli CH
    Pharmacol Biochem Behav; 2017 Jan; 152():30-35. PubMed ID: 27461546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
    Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
    J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
    Nguyen TV; Yao M; Pike CJ
    Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Curcumin Combined With the 5-alpha Reductase Inhibitor Dutasteride on LNCaP Prostate Cancer Cells.
    Nakayama A; Ide H; Lu Y; Takei A; Fukuda K; Osaka A; Arai G; Horie S; Okada H; Saito K
    In Vivo; 2021; 35(3):1443-1450. PubMed ID: 33910821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
    Hofbauer LC; Hicok KC; Khosla S
    J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells.
    Kamata YU; Sumida T; Murase R; Nakano H; Yamada T; Mori Y
    Anticancer Res; 2016 Nov; 36(11):6071-6075. PubMed ID: 27793934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice.
    Litim N; Morissette M; Caruso D; Melcangi RC; Di Paolo T
    J Steroid Biochem Mol Biol; 2017 Nov; 174():242-256. PubMed ID: 28982631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural androgen receptor regulation: effects of androgen and antiandrogen.
    Lu S; Simon NG; Wang Y; Hu S
    J Neurobiol; 1999 Dec; 41(4):505-12. PubMed ID: 10590174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.